Updated:
NOVIT Ventures
Artur Kluz and Wojciech Napiórkowski run NOVIT Ventures, the investment arm of Poland's USP Zdrowie, placing early-stage bets across CEE and the US.
NOVIT Ventures
NOVIT Ventures launched in 2015 as the dedicated investment arm of USP Group, a privately-held healthcare company founded by Wojciech Napiórkowski. USP Group controls USP Zdrowie, a leading consumer-health brand in Poland, and the venture arm was structured to redeploy the group's operational knowledge and distribution networks into external opportunities. The firm concentrates on early-stage companies at the intersection of healthcare, technology, and digital strategy. Its mandate spans direct equity investments, and the parent's pharmaceutical infrastructure in Wrocław and Warsaw provides a practical channel for portfolio companies seeking European market access. Confirmed geographic focus includes Central and Eastern Europe and North America, with the firm maintaining offices in Rockville, Maryland, and Warsaw, Poland. Napiórkowski is the primary beneficiary of the VN Trust, which owns USP Group, and Kluz leads the venture practice from Rockville. An affiliated office on Dupont Circle in Washington, D.C., is shared with Kluz Ventures, suggesting a single team operating under multiple banners. Kluz also chairs the University of Oxford's Centre for Technology and Global Affairs, linking the firm to academic-policy networks in Europe. The structure is defined by its deep operating-company attachment: NOVIT Ventures is not an independent fund manager raising blind pools but a captive vehicle for a pharma-and-consumer-health group. This makes its investment cadence, governance, and succession inseparable from the Napiórkowski family trust and USP Group's broader corporate strategy.
General information
Firm type
Venture Capital
Year founded
2015
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Rockville
Corporate office
966 Hungerford Drive, Suite 3B, Rockville, MD 20850, USA
Additional offices
Warsaw, Poland · Washington, DC, USA
Principals
Artur Kluz
Managing Partner
Wojciech Napiórkowski
Founder, USP Group
Sector focus
Frequently asked questions
How does NOVIT Ventures relate to USP Group?
NOVIT Ventures is the investment arm of USP Group, the owner of USP Zdrowie, a major Polish pharmaceutical and consumer-health company. The venture firm was created to invest the group's capital in external healthcare and technology startups, leveraging USP's distribution networks and digital-strategy experience across Central and Eastern Europe and North America.
Who runs investment decisions at NOVIT Ventures?
Artur Kluz is the Managing Partner of NOVIT Ventures and leads the investment practice from the firm's Rockville, Maryland office. Wojciech Napiórkowski, the founder of USP Group and primary beneficiary of the VN Trust that owns it, serves as the ultimate economic sponsor. Kluz also runs Kluz Ventures, which shares office space and branding with NOVIT Ventures.
Which sectors does NOVIT Ventures target?
The firm focuses on early-stage healthcare and technology companies. Its parent company's expertise sits in consumer health and digital strategy, and the venture arm explicitly looks to extend that competence into new areas of healthcare and adjacent technology sectors.
Is NOVIT Ventures structured as a family office or does it operate more like a venture firm?
It functions as a captive corporate venture vehicle rather than a traditional single-family office or a third-party fund manager. The capital comes from USP Group's Napiórkowski-controlled ownership structure, and the firm deploys it directly into early-stage deals, which makes it behave like a permanent-capital venture investor tied to a single operating company.
Where does NOVIT Ventures invest geographically?
The firm targets companies in Central and Eastern Europe and North America. Its physical footprint — offices in Rockville, Maryland, Washington, D.C., and Warsaw — reflects a transatlantic bridge strategy that connects US-based innovation with CEE market access through USP Group's distribution networks.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: